SS-31 10mg
99% HPLC PurityA mitochondria-targeted tetrapeptide studied for its affinity for cardiolipin.
A$79.99AUD
Tirzepatide 10mg
SKU: PW-014 • Batch: PW-260710
99.5% HPLC PurityCOA Verified ✓
Research-grade Tirzepatide 10mg lyophilised powder. 99.5% HPLC purity, COA verified. Dual GIP/GLP-1 receptor agonist for metabolic research.
Read the full description ↓A$68.39AUDA$75.99Sale
In Stock: Next-Day Dispatch
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Dispatched next business day (orders before 11PM AEST)
Frequently Bought Together
Retatrutide 10mg
99.4% HPLC PurityA triple GLP-1, GIP and glucagon receptor agonist, supplied as a 10mg lyophilised vial.
A$129.99AUD
Retatrutide 20mg
99.4% HPLC PurityThe same triple receptor agonist as our 10mg vial, supplied at double the strength.
A$219.99AUD
Key Research Features
- Dual receptor agonist: GIP and GLP-1
- 99.5% HPLC purity (independently verified)
- Full COA with mass spectrometry confirmation
- LAL endotoxin tested (<1.0 EU/mg)
- GMP-certified sourcing
- Lyophilised for maximum stability
Molecular Details
- Sequence
- LY3298176 (dual GIP/GLP-1 receptor agonist sequence; see COA for full data)
- Molecular Formula
- C₂₂₅H₃₄₈N₄₈O₆₈
- CAS Number
- 2023788-19-2
- Molecular Weight
- ~4813.5 Da
- Purity
- 99.5%
- Form
- Lyophilised powder
- Appearance
- White/off-white lyophilised powder
Purity independently verified at a leading Australian university via HPLC & mass spectrometry.
Usage & Storage
- Quantity
- 10mg / vial
- Dosage Notes
- Research protocols explore dual GIP/GLP-1 receptor agonist activity at varying concentrations. Consult published clinical literature for specific study designs.
- Reconstitution
- Reconstitute with 1–2mL bacteriostatic water. Swirl gently; do not shake. Allow to fully dissolve before use.
- Injection Route
- Subcutaneous (research protocols)
- Storage Temp
- −20°C for long-term storage
- Storage Conditions
- Store lyophilised at −20°C, protected from light. After reconstitution, refrigerate at 2–8°C and use within 4 weeks.
- Packaging
- Sterile, tamper-evident research vial
Description
Tirzepatide (LY3298176) is a dual receptor agonist targeting both the GIP and GLP-1 receptors. Supplied as a lyophilised powder at 99.5% HPLC purity with full Certificate of Analysis (COA) documentation.
Our Tirzepatide is sourced exclusively from GMP-certified manufacturing facilities with full chain-of-custody documentation maintained from synthesis to our Australian labs. Every batch undergoes independent third-party HPLC testing, mass spectrometry identity confirmation, LAL endotoxin assay (<1.0 EU/mg), and sterility screening before dispatch.
Research has explored Tirzepatide's simultaneous activation of the GIP and GLP-1 receptor pathways for effects on energy homeostasis, body composition, insulin sensitivity, and metabolic function, producing a distinct profile compared to single (GLP-1) receptor agonists studied in the literature.
Research & Guides
Frequently Asked Questions: Tirzepatide
Tirzepatide (LY3298176) is a dual GIP/GLP-1 receptor agonist investigated in preclinical and clinical research for its effects on metabolic function, body weight regulation, insulin sensitivity, and energy homeostasis. All use is strictly for in-vitro laboratory research only.
Our Tirzepatide 10mg is independently verified at 99.5% HPLC purity. Each batch is tested by an accredited third-party laboratory and comes with a full Certificate of Analysis (COA).
Lyophilised Tirzepatide should be stored at −20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2–8°C and use within 4 weeks. Avoid repeated freeze-thaw cycles.
Add bacteriostatic water (BAC water) slowly to the vial at a 1–2mL volume. Gently swirl; do not shake. Allow the lyophilised powder to dissolve completely before use in research protocols.
Tirzepatide is a dual agonist targeting the GIP and GLP-1 receptors, while Retatrutide is a triple agonist that also targets the glucagon receptor. In research settings, their differing receptor profiles produce distinct metabolic effects.
Yes. Tirzepatide is legal to purchase in Australia for legitimate in-vitro laboratory and research purposes. It is not approved for human consumption or therapeutic use.
Yes. Every batch of Tirzepatide ships with a downloadable COA including HPLC purity percentage, mass spectrometry identity confirmation, sterility results, and LAL endotoxin assay data.
Yes. Peptide Labs ships Tirzepatide nationwide across Australia via Australia Post with tracking. Orders placed before 11PM AEST are dispatched the next business day.
Research Use Only: Important Disclaimer
Tirzepatide 10mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
Reviews
Questions & Answers
No questions yet — be the first to ask about this product.